IO Biotech, Inc. - IOBT
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 13, 2026 | SCHEDULE 13G/A | Chernett Jorey | 6.3% | 4,543,532 | View |
| Feb 06, 2026 | SCHEDULE 13G | Point72 Asset Management, L.P. | 5.6% | 4,027,112 | View |
| Feb 06, 2026 | SCHEDULE 13G | Point72 Capital Advisors, Inc. | 5.6% | 4,027,112 | View |
| Feb 06, 2026 | SCHEDULE 13G | Steven A. Cohen | 5.6% | 4,027,112 | View |
| Jan 23, 2026 | SCHEDULE 13D/A | — | 3.3% | — | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Vivo Capital IX, LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Vivo Capital Fund IX, L.P. | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Vivo Opportunity, LLC | 4.6% | 3,157,894 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Vivo Opportunity Fund Holdings, L.P. | 4.6% | 3,157,894 | View |
| Nov 05, 2025 | SCHEDULE 13G | Chernett Jorey | 5.3% | 3,477,162 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.